- Indian pharma companies like Hetero, Alembic, Lupin, Dr Reddy’s dominating US generic space
Drug companies from India filed 51% of the overall global applications, also called drug master filings (DMF), in the US market during cale...
- Ranbaxy launches Daiichi Sankyo's heart disease drug in India
Ranbaxy Laboratories today launched a generic version of Prasugrel, used in treating heart diseases.
- Stocks to watch: Kingfisher Airlines, Ranbaxy, Unitech, SAIL, Patni Computers, BPCL
Patni Computers’ net profit for quarter ended December rose to $40.5 million vs $35.7 million and sales grew to $ 170.2 million against $16...
- Ranbaxy to market Daiichi’s products in Mexico
Daiichi Sankyo said its Indian arm Ranbaxy Laboratories will start selling its original products in Mexico as part of its strategy to lever...